These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 17148754

  • 1. Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts.
    Jesmin S, Zaedi S, Shimojo N, Iemitsu M, Masuzawa K, Yamaguchi N, Mowa CN, Maeda S, Hattori Y, Miyauchi T.
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1030-40. PubMed ID: 17148754
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart.
    Jesmin S, Zaedi S, Yamaguchi N, Maeda S, Shimojo N, Masuzawa K, Yamaguchi I, Goto K, Miyauchi T.
    Exp Biol Med (Maywood); 2006 Jun; 231(6):902-6. PubMed ID: 16741021
    [Abstract] [Full Text] [Related]

  • 3. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K, Jesmin S, Maeda S, Zaedi S, Shimojo N, Miyauchi T, Goto K.
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
    [Abstract] [Full Text] [Related]

  • 4. Effects of selective endothelin (ET)-A receptor antagonist versus dual ET-A/B receptor antagonist on hearts of streptozotocin-treated diabetic rats.
    Miyauchi Y, Jesmin S, Sakai S, Kamiyama J, Shimojo N, Rahman A, Islam M, Zaedi S, Maeda S, Maruyama H, Mizutani T, Homma S, Aonuma K, Miyauchi T.
    Life Sci; 2014 Aug 28; 111(1-2):6-11. PubMed ID: 24953608
    [Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor in diabetes induced early retinal abnormalities.
    Cukiernik M, Hileeto D, Evans T, Mukherjee S, Downey D, Chakrabarti S.
    Diabetes Res Clin Pract; 2004 Sep 28; 65(3):197-208. PubMed ID: 15331199
    [Abstract] [Full Text] [Related]

  • 6. Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease.
    Sasso FC, Torella D, Carbonara O, Ellison GM, Torella M, Scardone M, Marra C, Nasti R, Marfella R, Cozzolino D, Indolfi C, Cotrufo M, Torella R, Salvatore T.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):827-34. PubMed ID: 16139132
    [Abstract] [Full Text] [Related]

  • 7. Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats.
    Jesmin S, Zaedi S, Maeda S, Yamaguchi I, Goto K, Miyauchi T.
    Exp Biol Med (Maywood); 2006 Jun 06; 231(6):925-31. PubMed ID: 16741025
    [Abstract] [Full Text] [Related]

  • 8. Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodelling in a Type II diabetic rat model.
    Jesmin S, Sakuma I, Hattori Y, Fujii S, Kitabatake A.
    Diabetologia; 2002 Mar 06; 45(3):402-15. PubMed ID: 11914746
    [Abstract] [Full Text] [Related]

  • 9. Antagonism of endothelin action normalizes altered levels of VEGF and its signaling in the brain of stroke-prone spontaneously hypertensive rat.
    Jesmin S, Maeda S, Mowa CN, Zaedi S, Togashi H, Prodhan SH, Yamaguchi T, Yoshioka M, Sakuma I, Miyauchi T, Kato N.
    Eur J Pharmacol; 2007 Nov 28; 574(2-3):158-71. PubMed ID: 17689527
    [Abstract] [Full Text] [Related]

  • 10. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
    Gao L, Yu DM.
    Chin Med J (Engl); 2008 Nov 05; 121(21):2129-33. PubMed ID: 19080171
    [Abstract] [Full Text] [Related]

  • 11. VEGF signaling is disrupted in the hearts of mice lacking estrogen receptor alpha.
    Jesmin S, Mowa CN, Sultana SN, Shimojo N, Togashi H, Iwashima Y, Kato N, Sato A, Sakuma I, Hiroe M, Hattori Y, Yamaguchi N, Kobayashi H.
    Eur J Pharmacol; 2010 Sep 01; 641(2-3):168-78. PubMed ID: 20639141
    [Abstract] [Full Text] [Related]

  • 12. Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors.
    Chen S, Evans T, Mukherjee K, Karmazyn M, Chakrabarti S.
    J Mol Cell Cardiol; 2000 Sep 01; 32(9):1621-9. PubMed ID: 10966825
    [Abstract] [Full Text] [Related]

  • 13. Coordinated expression of Ets-1, pERK1/2, and VEGF in retina of streptozotocin-induced diabetic rats.
    Du ZJ, Kamei M, Suzuki M, Tano Y, Wang BR, Hui YN.
    Ophthalmic Res; 2007 Sep 01; 39(4):224-31. PubMed ID: 17622743
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor restores erectile function through modulation of the insulin-like growth factor system and sex hormone receptors in diabetic rat.
    Shirai M, Yamanaka M, Shiina H, Igawa M, Kawakami T, Ishii N, Lue TF, Fujime M, Dahiya R.
    Biochem Biophys Res Commun; 2006 Mar 17; 341(3):755-62. PubMed ID: 16455052
    [Abstract] [Full Text] [Related]

  • 15. Protective effects of a coumarin derivative in diabetic rats.
    Bucolo C, Ward KW, Mazzon E, Cuzzocrea S, Drago F.
    Invest Ophthalmol Vis Sci; 2009 Aug 17; 50(8):3846-52. PubMed ID: 19279317
    [Abstract] [Full Text] [Related]

  • 16. Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney.
    Komers R, Schutzer WE, Reed JF, Lindsley JN, Oyama TT, Buck DC, Mader SL, Anderson S.
    Diabetes; 2006 Jun 17; 55(6):1651-9. PubMed ID: 16731827
    [Abstract] [Full Text] [Related]

  • 17. Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes.
    Zoja C, Cattaneo S, Fiordaliso F, Lionetti V, Zambelli V, Salio M, Corna D, Pagani C, Rottoli D, Bisighini C, Remuzzi G, Benigni A.
    Am J Physiol Renal Physiol; 2011 Nov 17; 301(5):F1114-23. PubMed ID: 21816757
    [Abstract] [Full Text] [Related]

  • 18. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor.
    Yoon YS, Uchida S, Masuo O, Cejna M, Park JS, Gwon HC, Kirchmair R, Bahlman F, Walter D, Curry C, Hanley A, Isner JM, Losordo DW.
    Circulation; 2005 Apr 26; 111(16):2073-85. PubMed ID: 15851615
    [Abstract] [Full Text] [Related]

  • 19. Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats.
    Guo Z, Xia Z, Yuen VG, McNeill JH.
    Metabolism; 2007 Oct 26; 56(10):1363-71. PubMed ID: 17884446
    [Abstract] [Full Text] [Related]

  • 20. Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats.
    Chaudagar KK, Mehta AA.
    Clin Exp Hypertens; 2014 Oct 26; 36(8):557-66. PubMed ID: 24490705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.